Lepthien competitive analysis

Explore patent oppositions filed by Lepthien against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 19, 2026
Patent NumberTitleApplicantOpposition Date
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal IrinotecanIPSEN BIOPHARMOct 28, 2026
Manufacture Of DegarelixFERRINGOct 28, 2026
Formulation For Anti-Alpha4Beta7 AntibodyMILLENNIUM PHARMACEUTICALSSep 9, 2026

Latest PTAB cases involving Lepthien

Discover the latest PTAB cases involving Lepthien, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Lepthien with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 19, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LEPTHIEN3 - - -
FERRING825 - -
IPSEN BIOPHARM122 - 2
MILLENNIUM PHARMACEUTICALS - 21 - -